<meta charset="utf8"></head><body>Minimering av pigmentering vid laserbehandling med salicylsyra

<ol>
	<li>Ko, A. C., Korn, B. S., Kikkawa, D. O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+aging+face.">The aging face.</a> Surv Ophthalmol. 62 (2), 190-202 (2017).</li><li>Khavkin, J., Ellis, D. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Aging+skin:+histology,+physiology,+and+pathology.">Aging skin: histology, physiology, and pathology.</a> Facial Plast Surg Clin North Am. 19 (2), 229-234 (2011).</li><li>Horovitz, T., Clementoni, M. T., Artzi, O. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Nonablative+laser+skin+resurfacing+for+periorbital+wrinkling+-+A+case+series+of+16+patients.">Nonablative laser skin resurfacing for periorbital wrinkling - A case series of 16 patients.</a> J Cosmet Dermatol. 20 (1), 99-104 (2021).</li><li>Dou, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Fractional+microneedle+radiofrequency+device+and+fractional+erbium-doped+glass+1,565-nm+device+treatment+of+human+facial+photoaging:+a+prospective,+split-face,+random+clinical+trial.">Fractional microneedle radiofrequency device and fractional erbium-doped glass 1,565-nm device treatment of human facial photoaging: a prospective, split-face, random clinical trial.</a> J Cosmet Laser Ther. 23 (5-6), 142-148 (2021).</li><li>Wang, Y., Zheng, Y., Cai, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Efficacy+and+safety+of+1565-nm+non-ablative+fractional+laser+versus+long-pulsed+1064-nm+Nd:YAG+laser+in+treating+enlarged+facial+pores.">Efficacy and safety of 1565-nm non-ablative fractional laser versus long-pulsed 1064-nm Nd:YAG laser in treating enlarged facial pores.</a> Lasers Med Sci. 37 (8), 3279-3284 (2022).</li><li>Lin, A. N., Nakatsui, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Salicylic+acid+revisited.">Salicylic acid revisited.</a> Int J Dermatol. 37 (5), 335-342 (1998).</li><li>Arif, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Salicylic+acid+as+a+peeling+agent:+a+comprehensive+review.">Salicylic acid as a peeling agent: a comprehensive review.</a> Clin Cosmet Investig Dermatol. 8, 455-461 (2015).</li><li>Zhang, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=30%+supramolecular+salicylic+acid+peels+effectively+treats+acne+vulgaris+and+reduces+facial+sebum.">30% supramolecular salicylic acid peels effectively treats acne vulgaris and reduces facial sebum.</a> J Cosmet Dermatol. 21 (8), 3398-3405 (2022).</li><li>Zheng, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Efficacy+and+safety+of+2%+supramolecular+salicylic+acid+compared+with+5%+benzoyl+peroxide/0.1%+adapalene+in+the+acne+treatment:+a+randomized,+split-face,+open-label,+single-center+study.">Efficacy and safety of 2% supramolecular salicylic acid compared with 5% benzoyl peroxide/0.1% adapalene in the acne treatment: a randomized, split-face, open-label, single-center study.</a> Cutan Ocul Toxicol. 38 (1), 48-54 (2019).</li><li>Han, Q., Zeng, J., Liu, Y., Yin, J., Sun, P., Wu, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Evaluation+of+30%+supramolecular+salicylic+acid+followed+by+1565-nm+non-ablative+fractional+laser+on+facial+acne+and+subsequent+enlarged+pores.">Evaluation of 30% supramolecular salicylic acid followed by 1565-nm non-ablative fractional laser on facial acne and subsequent enlarged pores.</a> Lasers Med Sci. 38 (1), 91 (2023).</li><li>Salter, S. A., Kimball, A. B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Striae+gravidarum.">Striae gravidarum.</a> Clin Dermatol. 24 (2), 97-100 (2006).</li><li>Li, Y. J. Z., Luo, S., Xu, K. X., Hao, L. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Clinical+observation+of+the+injection+of+autologous+concentrated+growth+factors+(CGF)+in+the+improvement+of+facial+inflammaging.">Clinical observation of the injection of autologous concentrated growth factors (CGF) in the improvement of facial inflammaging.</a> Chin J Aesth Plast Surg. 30 (4), 236-239 (2019).</li><li>Munavalli, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+Split-face+assessment+of+the+synergistic+potential+of+sequential+Q-switched+Nd:YAG+laser+and+1565+nm+fractional+nonablative+laser+treatment+for+facial+rejuvenation+in+Fitzpatrick+skin+Type+II-V+patients.">A Split-face assessment of the synergistic potential of sequential Q-switched Nd:YAG laser and 1565 nm fractional nonablative laser treatment for facial rejuvenation in Fitzpatrick skin Type II-V patients.</a> J Drugs Dermatol. 15 (11), 1335-1342 (2016).</li><li>Chan, H. H., Manstein, D., Yu, C. S., Shek, S., Kono, T., Wei, W. I. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+prevalence+and+risk+factors+of+post-inflammatory+hyperpigmentation+after+fractional+resurfacing+in+Asians.">The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians.</a> Lasers Surg Med. 39 (5), 381-385 (2007).</li><li>Gold, M. H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+future+of+non-invasive+rejuvenation+technology:+Devices.">The future of non-invasive rejuvenation technology: Devices.</a> J Drugs Dermatol. 16 (6), s104-s107 (2017).</li><li>Lu, J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Salicylic+acid+treats+acne+vulgaris+by+suppressing+AMPK/SREBP1+pathway+in+sebocytes.">Salicylic acid treats acne vulgaris by suppressing AMPK/SREBP1 pathway in sebocytes.</a> Exp Dermatol. 28 (7), 786-794 (2019).</li></ol>

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>ResurFX fiber optic laser</td>
			<td>Lumenis, Yokneam, Israel</td>
			<td>M22 system</td>
			<td>1565 nm non-ablative fractional laser</td>
		</tr>
		<tr>
			<td>ISEMECO skin detector&#160;</td>
			<td>Isomeco Biomedical Technology Co., Ltd.,Shanghai, China</td>
			<td>MC-2600</td>
			<td>Skin testing can be conducted under 5 types of spectrum</td>
		</tr>
		<tr>
			<td>Compound lidocaine cream</td>
			<td>Beijing Unigroup Pharmaceutical Co., Ltd., China</td>
			<td>Guo Yao Quan Zi H20063466</td>
			<td>This product is a compound preparation, consisting of prilocaine and lidocaine. Each gram of this product contains 25 mg of prilocaine and 25 mg of lidocaine.</td>
		</tr>
		<tr>
			<td>30% supramolecular salicylic acid</td>
			<td>BRODA, Shanghai Ruizhi Medical Technology Co., Ltd., China</td>
			<td>N/A</td>
			<td>It can be used for anti-inflammatory and repairing the skin barrier.</td>
		</tr>
	</tbody>
</table>

enhancement of facial rejuvenation through a combination of 1565 nm non-ablative fractional laser with 30% supramolecular salicylic acid

Facial aging usually refers to the changes that occur after aging, such as bone shrinkage and deformation, soft tissue relaxation and sagging, increased skin pigmentation, and wrinkles, among which the aging of the skin is the most obvious1. The causes of facial aging are divided into exogenous and endogenous factors. Exogenous aging is caused by gravity, UV radiation, air pollution, smoking, excessive alcohol consumption, and malnutrition, among other factors2. Endogenous aging is mainly an inevitable aging process caused by genetics and age. With the pursuit of a beautiful image by those seeking beauty, various technologies and treatment concepts have emerged. Among them, photonic beauty treatments have developed rapidly in the treatment of facial aging in recent years. According to statistics from the International Society of Aesthetic Plastic Surgery, the number of patients undergoing photonic beauty treatments in the United States in 2020 increased by 15.2% compared to 20193.
Currently, there are various laser devices available for treating skin aging. These lasers are primarily used to reduce wrinkles and improve enlarged pores and can be categorized as ablative or non-ablative lasers. Non-ablative lasers, such as different wavelengths of erbium-doped glass (Er:Glass) lasers (1540 nm, 1550 nm, 1565 nm), are representative instruments for this purpose, with the ResurFX fiber optic laser being the most commonly used. The 1565 nm laser emitted by ResurFX can stimulate dermal collagen remodeling while maintaining the integrity of the epidermis. It has shown good efficacy and high safety for the treatment of periorbital wrinkles4. A prospective study has confirmed that non-ablative fractional lasers can improve various facial skin concerns, such as laxity, wrinkles, and coarse pores, among Asian patients, and the patients were satisfied with the treatment outcomes5. However, posttreatment complications such as pain, erythema, edema, crust formation, inflammatory hyperpigmentation, and acne eruptions were reported in 100% of cases treated with non-ablative fractional lasers. Currently, in order to alleviate the adverse reactions during and after non-ablative fractional laser treatment, methods include a topical anesthetic ointment that can be applied before treatment to improve treatment tolerance, and an adequate cold compress after laser treatment can shorten the duration of erythema and edema6. However, these treatments have limited effects in reducing pain and erythema edema and still cannot make all patients accept non-ablative fractional laser treatment.
Salicylic acid (SA) is a &#946;-hydroxy acid extracted from willow bark, etc.7, with a concentration of 2% ~ 30%. SA can remove lipids between cells, reduce the adhesion of keratin-forming cells, and cause these cells to loosen and subsequently separate8. In addition, it has antibacterial, antifungal, and some anesthetic effects9. However, SA has poor solubility in water and easily precipitates in low-pH alcohol solutions and irritating solvents to the skin. To solve these limitations, supramolecular SA (SSA) was introduced. It forms water-soluble supramolecular entities in the form of intermolecular complexes through reversible non-covalent bonding and releases slowly during use, reaching maximum efficacy under low-pH conditions and reducing skin irritation10. Zhang et al.9. measured skin hydration, transepidermal water loss (TEWL), pH value of skin barrier-related parameters. After four treatments, TEWL decreased, while skin hydration and pH values increased. These results suggested that 30% of SSA peels did not damage the skin barrier function but improved instead.
Therefore, some scholars advocate the use of non-ablative fractional laser combined with SSA chemical peel treatment to improve problems such as large pores and acne11. However, according to the author's experience, the immediate use of SSA chemical peel treatment after 1565 nm non-ablative fractional laser treatment has not been fully utilized in clinical practice, which may be due to different treatment sequences in previous clinical practice. This article introduces a new treatment method to improve the adverse reactions after 1565 nm non-ablative fractional laser treatment, combined with relevant visual aids, in order to help more patients receive 1565 nm non-ablative fractional laser treatment for facial rejuvenation.

<meta charset="utf8"></head><body>Författare i fokus: Avancerad ansiktsföryngringsterapi med applicering av salicylsyra efter laser

Förbättring av ansiktsföryngring genom en kombination av 1565 nm icke-ablativ fraktionerad laser med 30 % supramolekylär salicylsyra

My research focuses on facial rejuvenation and I want to translate clinical experience into evidence-based medical results through clinical trials. Currently, several clinicians have implemented the use of 30%super molecular salicylic acid immediately following 1, 565 nanometer non-ablative fractional laser treatment, discovering that this combined approach outperforms the sole application of 1565 nanometer non-ablative fractional laser. Our research validates this finding and further demonstrates that the distinct advantage of this combined therapy its effectiveness in resolving pigmented and reddened areas.Our method can reduce the incidence of post laser pigmentation and expedite the fading of post laser erythema. Moreover, the combined treatment also reduces the number of hospital visits for patients.

The 1565 nm non-ablative fractional laser can effectively stimulate collagen regeneration, achieving the effect of skin rejuvenation and anti-aging. In ...

enhancement-facial-rejuvenation-through-combination-1565-nm-non

Research

JoVE Journal

Medicine

Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid

494 Views.  Chongqing Medical University. My research focuses on facial rejuvenation and I want to translate clinical experience into evidence-based medical results through clinical trials. Currently, several clinicians have implemented the use of 30%super molecular salicylic acid immediately following 1, 565 nanometer non-ablative fractional laser treatment, discovering that this combined approach outperforms the sole application of 1565 nanometer non-ablative fractional laser. Our research validates this finding and further demonst...